Annual EBITDA
-$19.63 M
-$307.00 K-1.59%
31 December 2021
Summary:
Viveve Medical annual earnings before interest, taxes, depreciation & amortization is currently -$19.63 million, with the most recent change of -$307.00 thousand (-1.59%) on 31 December 2021. During the last 3 years, it has fallen by -$307.00 thousand (-1.59%). VIVE annual EBITDA is now -604.81% below its all-time high of $3.89 million, reached on 31 December 2013.VIVE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$4.51 M
+$362.00 K+7.43%
30 September 2022
Summary:
Viveve Medical quarterly earnings before interest, taxes, depreciation & amortization is currently -$4.51 million, with the most recent change of +$362.00 thousand (+7.43%) on 30 September 2022. VIVE quarterly EBITDA is now -156.23% below its all-time high of $8.02 million, reached on 30 June 2013.VIVE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$20.43 M
+$814.00 K+3.83%
30 September 2022
Summary:
Viveve Medical TTM earnings before interest, taxes, depreciation & amortization is currently -$20.43 million, with the most recent change of +$814.00 thousand (+3.83%) on 30 September 2022. VIVE TTM EBITDA is now -321.78% below its all-time high of $9.21 million, reached on 31 March 2014.VIVE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VIVE EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -1.6% | +15.3% | -13.5% |
| 5 y5 years | +55.5% | +28.5% | +41.5% |
VIVE EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.6% | at low | at high | +21.6% | -13.5% | +3.8% |
| 5 y | 5 years | -1.6% | +55.5% | -44.0% | +66.4% | -29.2% | +43.8% |
| alltime | all time | -604.8% | +55.5% | -156.2% | +66.4% | -321.8% | +53.8% |
Viveve Medical EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$4.51 M(-7.4%) | -$20.43 M(-3.8%) |
| June 2022 | - | -$4.87 M(-7.9%) | -$21.24 M(+7.4%) |
| Mar 2022 | - | -$5.29 M(-8.1%) | -$19.77 M(+0.7%) |
| Dec 2021 | -$19.63 M(+1.6%) | -$5.75 M(+8.1%) | -$19.63 M(+9.1%) |
| Sept 2021 | - | -$5.32 M(+56.5%) | -$18.00 M(+13.9%) |
| June 2021 | - | -$3.40 M(-34.0%) | -$15.81 M(-16.3%) |
| Mar 2021 | - | -$5.15 M(+25.0%) | -$18.89 M(-2.3%) |
| Dec 2020 | -$19.32 M(-46.9%) | -$4.12 M(+31.6%) | -$19.32 M(-32.5%) |
| Sept 2020 | - | -$3.13 M(-51.6%) | -$28.63 M(-10.0%) |
| June 2020 | - | -$6.48 M(+15.9%) | -$31.80 M(-5.0%) |
| Mar 2020 | - | -$5.59 M(-58.4%) | -$33.49 M(-7.9%) |
| Dec 2019 | -$36.36 M(-17.7%) | -$13.43 M(+112.9%) | -$36.36 M(+4.1%) |
| Sept 2019 | - | -$6.31 M(-22.7%) | -$34.94 M(-11.5%) |
| June 2019 | - | -$8.16 M(-3.6%) | -$39.48 M(-4.7%) |
| Mar 2019 | - | -$8.47 M(-29.4%) | -$41.43 M(-6.2%) |
| Dec 2018 | -$44.17 M(+32.5%) | -$12.00 M(+10.5%) | -$44.17 M(+6.4%) |
| Sept 2018 | - | -$10.86 M(+7.4%) | -$41.52 M(+5.5%) |
| June 2018 | - | -$10.11 M(-9.7%) | -$39.36 M(+3.0%) |
| Mar 2018 | - | -$11.20 M(+19.7%) | -$38.23 M(+14.6%) |
| Dec 2017 | -$33.34 M(+79.0%) | -$9.36 M(+7.7%) | -$33.36 M(+13.0%) |
| Sept 2017 | - | -$8.69 M(-3.2%) | -$29.53 M(+16.1%) |
| June 2017 | - | -$8.98 M(+42.0%) | -$25.44 M(+21.3%) |
| Mar 2017 | - | -$6.33 M(+14.3%) | -$20.98 M(+12.6%) |
| Dec 2016 | -$18.63 M(+56.1%) | -$5.53 M(+20.2%) | -$18.63 M(+12.0%) |
| Sept 2016 | - | -$4.60 M(+1.8%) | -$16.64 M(+10.0%) |
| June 2016 | - | -$4.52 M(+13.7%) | -$15.12 M(+12.1%) |
| Mar 2016 | - | -$3.98 M(+12.2%) | -$13.48 M(+13.0%) |
| Dec 2015 | -$11.93 M(+114.8%) | -$3.54 M(+14.9%) | -$11.93 M(+18.9%) |
| Sept 2015 | - | -$3.08 M(+7.0%) | -$10.04 M(+8.1%) |
| June 2015 | - | -$2.88 M(+18.9%) | -$9.29 M(+132.5%) |
| Mar 2015 | - | -$2.42 M(+47.2%) | -$3.99 M(+2.3%) |
| Dec 2014 | -$5.56 M(-242.9%) | -$1.65 M(-29.4%) | -$3.91 M(-317.0%) |
| Sept 2014 | - | -$2.33 M(-196.8%) | $1.80 M(-50.0%) |
| June 2014 | - | $2.41 M(-203.2%) | $3.60 M(-60.9%) |
| Mar 2014 | - | -$2.34 M(-157.6%) | $9.21 M(+136.7%) |
| Dec 2013 | $3.89 M(-149.9%) | $4.06 M(-861.5%) | $3.89 M(+28.4%) |
| Sept 2013 | - | -$533.00 K(-106.6%) | $3.03 M(+454.1%) |
| June 2013 | - | $8.02 M(-204.8%) | $547.00 K(-106.2%) |
| Mar 2013 | - | -$7.66 M(-339.3%) | -$8.79 M(+12.8%) |
| Dec 2012 | -$7.79 M(+18.3%) | $3.20 M(-206.0%) | -$7.79 M(-34.5%) |
| Sept 2012 | - | -$3.02 M(+129.3%) | -$11.89 M(+29.8%) |
| June 2012 | - | -$1.32 M(-80.2%) | -$9.16 M(+10.8%) |
| Mar 2012 | - | -$6.66 M(+636.2%) | -$8.27 M(+25.6%) |
| Dec 2011 | -$6.58 M(+114.7%) | -$904.00 K(+217.2%) | -$6.58 M(+7.8%) |
| Sept 2011 | - | -$285.00 K(-32.8%) | -$6.11 M(-6.0%) |
| June 2011 | - | -$424.00 K(-91.5%) | -$6.50 M(-7.6%) |
| Mar 2011 | - | -$4.97 M(+1058.7%) | -$7.03 M(+115.2%) |
| Dec 2010 | -$3.07 M(+100.1%) | -$429.00 K(-36.7%) | -$3.27 M(-4.5%) |
| Sept 2010 | - | -$678.00 K(-29.1%) | -$3.42 M(+11.1%) |
| June 2010 | - | -$956.00 K(-20.7%) | -$3.08 M(+28.0%) |
| Mar 2010 | - | -$1.21 M(+107.2%) | -$2.41 M(+57.0%) |
| Dec 2009 | -$1.53 M(-21.9%) | -$582.00 K(+73.2%) | -$1.53 M(+37.2%) |
| Sept 2009 | - | -$336.00 K(+18.7%) | -$1.12 M(-0.1%) |
| June 2009 | - | -$283.00 K(-14.8%) | -$1.12 M(-25.8%) |
| Mar 2009 | - | -$332.00 K(+100.0%) | -$1.51 M(-23.3%) |
| Dec 2008 | -$1.96 M(-27.2%) | -$166.00 K(-50.7%) | -$1.96 M(-26.9%) |
| Sept 2008 | - | -$337.00 K(-49.8%) | -$2.69 M(-8.1%) |
| June 2008 | - | -$671.00 K(-15.1%) | -$2.92 M(+8.1%) |
| Mar 2008 | - | -$790.00 K(-11.1%) | -$2.70 M(+0.2%) |
| Dec 2007 | -$2.70 M(-363.0%) | -$889.00 K(+55.1%) | -$2.70 M(+46.4%) |
| Sept 2007 | - | -$573.00 K(+26.8%) | -$1.84 M(+27.2%) |
| June 2007 | - | -$452.00 K(-42.3%) | -$1.45 M(+42.8%) |
| Mar 2007 | - | -$784.00 K(+2205.9%) | -$1.01 M(-198.9%) |
| Dec 2006 | $1.03 M | -$34.00 K(-81.0%) | $1.03 M(+59.8%) |
| Sept 2006 | - | -$179.00 K(+894.4%) | $642.00 K(+66.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2006 | - | -$18.00 K(-101.4%) | $385.00 K(+358.3%) |
| Mar 2006 | - | $1.26 M(-400.7%) | $84.00 K(-106.1%) |
| Dec 2005 | -$1.38 M(+65.2%) | -$418.00 K(-4.1%) | -$1.38 M(+86.2%) |
| Sept 2005 | - | -$436.00 K(+36.7%) | -$739.00 K(+3.1%) |
| June 2005 | - | -$319.00 K(+57.1%) | -$717.00 K(+5.3%) |
| Mar 2005 | - | -$203.00 K(-192.7%) | -$681.00 K(-18.2%) |
| Dec 2004 | -$833.00 K(-199.6%) | $219.00 K(-152.9%) | -$833.00 K(+16.5%) |
| Sept 2004 | - | -$414.00 K(+46.3%) | -$715.00 K(+1017.2%) |
| June 2004 | - | -$283.00 K(-20.3%) | -$64.00 K(-114.4%) |
| Mar 2004 | - | -$355.00 K(-205.3%) | $445.00 K(-46.8%) |
| Dec 2003 | $836.00 K(+89.1%) | $337.00 K(+42.2%) | $836.00 K(+14.7%) |
| Sept 2003 | - | $237.00 K(+4.9%) | $729.00 K(-2.1%) |
| June 2003 | - | $226.00 K(+527.8%) | $745.00 K(+7.3%) |
| Mar 2003 | - | $36.00 K(-84.3%) | $694.00 K(+57.0%) |
| Dec 2002 | $442.00 K(-113.6%) | $230.00 K(-9.1%) | $442.00 K(-759.7%) |
| Sept 2002 | - | $253.00 K(+44.6%) | -$67.00 K(-94.4%) |
| June 2002 | - | $175.00 K(-181.0%) | -$1.21 M(-49.1%) |
| Mar 2002 | - | -$216.00 K(-22.6%) | -$2.37 M(-27.1%) |
| Dec 2001 | -$3.25 M(-21.9%) | -$279.00 K(-68.5%) | -$3.25 M(-20.3%) |
| Sept 2001 | - | -$887.00 K(-10.1%) | -$4.08 M(+1.0%) |
| June 2001 | - | -$987.00 K(-9.9%) | -$4.03 M(+11.9%) |
| Mar 2001 | - | -$1.10 M(-0.9%) | -$3.60 M(-13.4%) |
| Dec 2000 | -$4.16 M(-5.2%) | -$1.11 M(+30.9%) | -$4.16 M(+28.3%) |
| Sept 2000 | - | -$845.00 K(+51.4%) | -$3.24 M(-12.3%) |
| June 2000 | - | -$558.00 K(-66.2%) | -$3.70 M(-20.3%) |
| Mar 2000 | - | -$1.65 M(+779.3%) | -$4.64 M(+3.4%) |
| Dec 1999 | -$4.39 M(-68.4%) | -$188.00 K(-85.5%) | -$4.49 M(-28.8%) |
| Sept 1999 | - | -$1.30 M(-13.3%) | -$6.30 M(-25.0%) |
| June 1999 | - | -$1.50 M(0.0%) | -$8.40 M(-28.8%) |
| Mar 1999 | - | -$1.50 M(-25.0%) | -$11.80 M(-14.5%) |
| Dec 1998 | -$13.90 M(+10.7%) | -$2.00 M(-41.2%) | -$13.80 M(-15.1%) |
| Sept 1998 | - | -$3.40 M(-30.6%) | -$16.26 M(+1.9%) |
| June 1998 | - | -$4.90 M(+40.0%) | -$15.96 M(+19.5%) |
| Mar 1998 | - | -$3.50 M(-21.5%) | -$13.36 M(+6.4%) |
| Dec 1997 | -$12.56 M(+1469.9%) | -$4.46 M(+43.8%) | -$12.56 M(+35.0%) |
| Sept 1997 | - | -$3.10 M(+34.8%) | -$9.30 M(+43.1%) |
| June 1997 | - | -$2.30 M(-14.8%) | -$6.50 M(+27.5%) |
| Mar 1997 | - | -$2.70 M(+125.0%) | -$5.10 M(+363.6%) |
| Dec 1996 | -$800.00 K(-140.0%) | -$1.20 M(+300.0%) | -$1.10 M(-75.0%) |
| Sept 1996 | - | -$300.00 K(-66.7%) | -$4.40 M(+76.0%) |
| June 1996 | - | -$900.00 K(-169.2%) | -$2.50 M(+2400.0%) |
| Mar 1996 | - | $1.30 M(-128.9%) | -$100.00 K(-106.7%) |
| Dec 1995 | $2.00 M(-180.0%) | -$4.50 M(-381.3%) | $1.50 M(-73.2%) |
| Sept 1995 | - | $1.60 M(+6.7%) | $5.60 M(+86.7%) |
| June 1995 | - | $1.50 M(-48.3%) | $3.00 M(+233.3%) |
| Mar 1995 | - | $2.90 M(-825.0%) | $900.00 K(-134.6%) |
| Dec 1994 | -$2.50 M(-35.9%) | -$400.00 K(-60.0%) | -$2.60 M(-18.8%) |
| Sept 1994 | - | -$1.00 M(+66.7%) | -$3.20 M(+3.2%) |
| June 1994 | - | -$600.00 K(0.0%) | -$3.10 M(-16.2%) |
| Mar 1994 | - | -$600.00 K(-40.0%) | -$3.70 M(-5.1%) |
| Dec 1993 | -$3.90 M(+25.8%) | -$1.00 M(+11.1%) | -$3.90 M(0.0%) |
| Sept 1993 | - | -$900.00 K(-25.0%) | -$3.90 M(+11.4%) |
| June 1993 | - | -$1.20 M(+50.0%) | -$3.50 M(+9.4%) |
| Mar 1993 | - | -$800.00 K(-20.0%) | -$3.20 M(0.0%) |
| Dec 1992 | -$3.10 M(+72.2%) | -$1.00 M(+100.0%) | -$3.20 M(-23.8%) |
| Sept 1992 | - | -$500.00 K(-44.4%) | -$4.20 M(+16.7%) |
| June 1992 | - | -$900.00 K(+12.5%) | -$3.60 M(+38.5%) |
| Mar 1992 | - | -$800.00 K(-60.0%) | -$2.60 M(+52.9%) |
| Dec 1991 | -$1.80 M(<-9900.0%) | -$2.00 M(-2100.0%) | -$1.70 M(-950.0%) |
| Sept 1991 | - | $100.00 K(0.0%) | $200.00 K(0.0%) |
| June 1991 | - | $100.00 K(0.0%) | $200.00 K(0.0%) |
| Mar 1991 | - | $100.00 K(-200.0%) | $200.00 K(0.0%) |
| Dec 1990 | $0.00 | -$100.00 K(-200.0%) | $200.00 K(-33.3%) |
| Sept 1990 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| June 1990 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1990 | - | $100.00 K | $100.00 K |
FAQ
- What is Viveve Medical annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Viveve Medical?
- What is Viveve Medical quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Viveve Medical?
- What is Viveve Medical TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Viveve Medical?
What is Viveve Medical annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of VIVE is -$19.63 M
What is the all time high annual EBITDA for Viveve Medical?
Viveve Medical all-time high annual earnings before interest, taxes, depreciation & amortization is $3.89 M
What is Viveve Medical quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of VIVE is -$4.51 M
What is the all time high quarterly EBITDA for Viveve Medical?
Viveve Medical all-time high quarterly earnings before interest, taxes, depreciation & amortization is $8.02 M
What is Viveve Medical TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of VIVE is -$20.43 M
What is the all time high TTM EBITDA for Viveve Medical?
Viveve Medical all-time high TTM earnings before interest, taxes, depreciation & amortization is $9.21 M